Novavax Covid Jab Highly Effective, But Not Against South Africa Variant

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...

from NDTV News - Topstories https://ift.tt/36lyTbO

Comments

Popular posts from this blog

Gurugram Man Kidnaps Toddler For Childless Sister, Arrested: Cops

Cannes 2024: Sobhita Adds Sparkle And Glam. See French Riviera Album